Clinical practice guide: biologic therapies in Psoriasis. By Javier Labandeira GarcÃa.
Spain, March of 2013.- this year 2013 meets the 15 anniversary of the adoption of the first drugs anti tumor necrosis factor alpha to not skin autoimmune diseases, and the tenth anniversary of the adoption of the first biological drug for psoriasis, however this type of biological treatments are still in phase of new medication” by which continue to generate plenty of medical studies, case studies, guides and all kinds of recommendations of the different academies, societies and dermatological societies.
Get a guide, collection, based only on the evidence of major studies and existing recommendations in the literature on biological therapies in psoriasis, it was a very complicated task.
If in addition we intended that this guide had the certification of its authors, which was made fully autonomous and independently, without any conflict of interest and without any sponsor would have interfered in the content, the search would be difficult.
Guidelines clinica:
Biological therapies in Psoriasis.
To solve that vacuum the dermatologic literature, doctor Javier Labandeira, drafted, after more than three years of painstaking research, the clinical practice guidelines that just came out light. The most comprehensive medical guide on biological therapies in psoriasis currently posted.
Dr. Javier Labandeira GarcÃa is dermatologist of the service of Dermatology of the complex Hospital University of Santiago de Compostela (Spain) and directs the day Hospital for treatment with biological and non-biological agents of that service.
cover.
This guide not only shows us the guideline to follow with the biological treatment for psoriasis, but it is a complete and practical guide that will allow us to learn more about psoriasis, psoriatic arthritis and their respective and countless co-morbidities (Diabetes Mellitus, metabolic syndrome(, Cardiovascular disease, lymphoma, Melanoma, psychological alterations etc …) and of its different treatments according to the clinical situation in each case, with the primary objective of providing a tool based on evidence enabling it to decide, safely, on the most appropriate treatment for each patient’s psoriasis dermatologist.
The many chapters of this extensive guide (more than 420 pages) indicate the complete that results for the treatment of psoriasis (pso) and the well that is grouped content for convenient reference:
Chapter 1 – evaluation of psoriasis (assessment of severity of psoriasis and different methods to assess it).
Chapter 2 – therapeutic options in pso.
Chapter 3 – General aspects of biological therapy in pso.
Chapter 4 – efficacy of biological therapy in pso.
Chap. 5 – therapies combined in pso.
Chapter 6 – treatment of the pso. in complex clinical situations or special circumstances.
Chapter 7 – Psoriasis nail. Evaluation and treatment.
Chapter 8 – arthritis psoriatic. Evaluation and treatment.
Chapter 9 – Comorbidities associated with pso.
Chapter 10 – cardiovascular risk in people with pso, evaluation and correction.
Chapter 11 – safety and biological therapies.
Ch. 12 – Tuberculosis and biological therapies.
Chapter 13 – vaccination and biological therapies.
Chap. 14 – cost-effectiveness of biologic therapies in pso.
Chapters we will always find conclusions and/or recommendations that are very important, in addition to being completed with its corresponding bibliographic references.
The distribution of this clinical practice guidelines: biologic therapies in Psoriasis, is being exclusively to dermatologists via delegates and also web.
Coinciding with Dr. Jaime Toribio Pérez, Professor of Dermatology of the University of Santiago de Compostela (Spain) and author of the introduction to this guide, it is a great job and I am sure of its success and usefulness for dermatologists.
My Special thanks to Dr. Javier Labandeira by sending a copy of this guide.
